United States · FDA National Drug Code directory
LidexaGel 5%
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85477-730_3899614e-a1ed-4642-937b-5d8e55a81c9a
- Product NDC
- 85477-730
- Form
- GEL
- Composition / generic term
- Lidocaine HCl
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260701
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 85 g in 1 TUBE (85477-730-07) · 85477-730-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →